Bioreactor recombinant production of SARS-CoV-2 virus antigens in cho cell clones by using new ucoe lentiviral vector system
Yükleniyor...
Tarih
2023
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier Science Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background & Aim: The new UCOE models we have recently developed, tested on many cell groups (including mouse ES and human iPS
cells) and human mAb recombinant production studies as well, shows
a powerful resistance to DNA methylation- mediated silencing and
provides a higher and stable transfection profile. By the urgent need
of vaccine development for COVID-19 during the pandemic, in this
study we aimed to produce a potential recombinant vaccine by using
the new generation UCOEs models of our own design
Açıklama
Anahtar Kelimeler
SARS-CoV-2, UCOE, Recombinant Vaccine
Kaynak
Cytotherapy
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
25
Sayı
6
Künye
Anakok, O. F., Kose, P., & Bayindirli, K. N. (2023). Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM. Cytotherapy, 25(6), S258.
